XML 29 R38.htm IDEA: XBRL DOCUMENT v3.20.1
Stock Based Compensation (Tables)
12 Months Ended
Dec. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Summary of Recognized Stock Based Compensation

The following table summarizes employee and nonemployee stock based compensation for the years ended December 31, 2019 and 2018:

 

 

 

Year Ending December 31,

 

Amounts in (000's)

 

2019

 

 

2018

 

Employee compensation:

 

 

 

 

 

 

 

 

Restricted stock

 

$

 

 

$

15

 

Total employee stock-based compensation

   expense

 

$

 

 

$

15

 

Non-employee compensation:

 

 

 

 

 

 

 

 

Restricted stock

 

$

92

 

 

$

161

 

Total non-employee stock-based compensation

   expense

 

$

92

 

 

$

161

 

Total stock-based compensation expense

 

$

92

 

 

$

176

 

Summary of Company's Stock Option Activity

The following summarizes the Company’s employee and non-employee stock option activity for the years ended December 31, 2019 and 2018:

 

 

 

Number of

Options

(000's)

 

 

Weighted

Average

Exercise

Price

 

 

Weighted

Average

Remaining

Contract Life

(in years)

 

 

Aggregate

Intrinsic

Value (000's) (a)

 

Outstanding and vested at December 31, 2017

 

 

15

 

 

$

47.77

 

 

6.4

 

 

$

 

Outstanding and vested at December 31, 2018

 

 

15

 

 

$

47.77

 

 

 

5.4

 

 

$

 

Outstanding and vested at December 31, 2019

 

 

15

 

 

$

47.77

 

 

 

4.4

 

 

$

 

 

(a)

Represents the aggregate gain on exercise for vested in-the-money options.

Schedule of Exercise Price Range

The following summary information reflects stock options outstanding, vested and related details as of December 31, 2019:

 

 

 

Stock Options Outstanding

 

 

Stock Options

Exercisable

 

Exercise Price

 

Number

Outstanding

(000's)

 

 

Weighted

Average

Remaining

Contractual Term

(in years)

 

 

Weighted

Average

Exercise

Price

 

 

Vested and

Exercisable

(000's)

 

 

Weighted

Average

Exercise

Price

 

$15.72 - $47.99

 

 

10

 

 

 

4.7

 

 

$

46.84

 

 

 

10

 

 

$

46.84

 

$48.00 - $51.60

 

 

5

 

 

 

3.7

 

 

$

49.42

 

 

 

5

 

 

$

49.42

 

Total

 

 

15

 

 

 

4.4

 

 

$

47.77

 

 

 

15

 

 

$

47.77

 

Summary of Company's Restricted Stock Activity

The following summarizes the Company’s restricted stock activity for the years ended December 31, 2019 and 2018:

 

 

 

Number

of

Shares (000's)

 

 

Weighted

Average

Grant Date

Fair Value

 

Unvested at December 31, 2017

 

 

13

 

 

$

21.91

 

Granted

 

 

41

 

 

$

3.60

 

Vested

 

 

(6

)

 

$

22.92

 

Forfeited

 

 

 

 

$

 

Unvested at December 31, 2018

 

 

48

 

 

$

6.20

 

Granted

 

 

 

 

$

 

Vested

 

 

(19

)

 

$

8.65

 

Forfeited

 

 

 

 

$

 

Unvested at December 31, 2019

 

 

29

 

 

$

4.63

 

Warrant  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of Exercise Price Range

The following summary information reflects warrants outstanding, vested and related details as of December 31, 2019:

 

 

 

Warrants Outstanding

 

 

Warrants Exercisable

 

Exercise Price

 

Number

Outstanding

(000's)

 

 

Weighted

Average

Remaining

Contractual

Term (in years)

 

 

Weighted

Average

Exercise

Price

 

 

Vested and

Exercisable

(000's)

 

 

Weighted

Average

Exercise

Price

 

$36.00 - $47.99

 

 

14

 

 

 

2.4

 

 

$

46.71

 

 

 

14

 

 

$

46.71

 

$48.00 - $59.99

 

 

42

 

 

 

4.5

 

 

$

52.99

 

 

 

42

 

 

$

52.99

 

$60.00 - $70.80

 

 

2

 

 

 

3.4

 

 

$

70.80

 

 

 

2

 

 

$

70.80

 

Total

 

 

58

 

 

 

4.0

 

 

$

52.09

 

 

 

58

 

 

$

52.09

 

Schedule of Common Stock Warrant Activity

The following summarizes the Company’s employee and non-employee common stock warrant activity for the years ended December 31, 2019 and 2018:

 

 

 

Number of

Warrants

(000's)

 

 

Weighted

Average

Exercise

Price

 

 

Weighted

Average

Remaining

Contract Life

(in years)

 

 

Aggregate

Intrinsic

Value (000's) (a)

 

Outstanding and vested at December 31, 2017

 

 

85

 

 

$

45.53

 

 

 

4.7

 

 

 

 

 

Outstanding and vested at December 31, 2018

 

 

85

 

 

$

45.53

 

 

 

3.7

 

 

$

 

Expired

 

 

(27

)

 

$

31.72

 

 

 

 

 

 

 

 

 

Outstanding and vested at December 31, 2019

 

 

58

 

 

$

52.09

 

 

 

4.0

 

 

$

 

 

(a)

Represents the aggregate gain on exercise for vested in-the-money warrants.